Almitas Capital’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55,000
Closed -$779K 117
2025
Q4
$779K Buy
+55,000
New +$796K 0.17% 66
2024
Q3
Sell
-44,339
Closed -$728K 69
2024
Q2
$728K Buy
+44,339
New +$713K 0.3% 56
2023
Q1
Sell
-925,786
Closed -$12.8M 101
2022
Q4
$12.8M Buy
925,786
+522,673
+130% +$7.38M 5.92% 4
2022
Q3
$5.49M Buy
403,113
+390,296
+3,045% +$5.8M 4.1% 6
2022
Q2
$188K Buy
+12,817
New +$198K 0.1% 71

Other funds holding BCAT

Almitas Capital's BCAT Position: Q1 2026 in Review

Almitas Capital sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2026, closing a stake of 55,000 shares — an estimated $779K sold.

Almitas Capital first reported a position in BCAT in Q2 2022 and held it in 5 quarters. The position peaked at $12.8M in Q4 2022. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

  • Almitas Capital reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2026 after selling out during the quarter.
  • Almitas Capital sold 55,000 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $779K.
  • Almitas Capital first reported a position in BlackRock Capital Allocation Term Trust in Q2 2022 and held it in 5 quarters.
  • Almitas Capital's BlackRock Capital Allocation Term Trust position peaked at $12.8M in Q4 2022.
  • 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on Almitas Capital's 13F filing for Q1 2026, filed 15 May 2026.